Comparison of drug-eluting and bare metal stents for saphenous vein graft lesions (from the national heart, lung, and blood institute dynamic registry)

American Journal of Cardiology

Volumn 106, Issue 7, 2010, Pages 946-951

  Baldwin, Drew E ^a   Abbott, J Dawn ^b   Trost, Jeffrey C ^c   Vlachos, Helen A ^d   Selzer, Faith ^d   Glaser, Ruchira ^e   Wilensky, Robert L ^f   Slater, James N ^g   Doucet, Serge ^h   Naidu, Srihari S ⁱ   Aronow, Herbert D ^j   Williams, David O ^k  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e CHRISTIANA HOSPITAL   (United States)

^f HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^g NEW YORK UNIVERSITY   (United States)

^h MONTREAL HEART INSTITUTE   (Canada)

ⁱ WINTHROP UNIVERSITY HOSPITAL   (United States)

^j Heart PC   (United States)

^k BRIGHAM AND WOMEN S HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BARE METAL STENT; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NATIONAL HEALTH ORGANIZATION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; SAPHENOUS VEIN GRAFT; STENT THROMBOSIS; TREATMENT OUTCOME; VEIN GRAFT DISEASE; CORONARY ARTERY DISEASE; SAPHENOUS VEIN;

AGED; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; SAPHENOUS VEIN; TREATMENT OUTCOME;

EID: 77956947461     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.05.025     Document Type: Article

References (19)

1. G.M. Fitzgibbon, H.P. Kafka, A.J. Leach, W.J. Keon, G.D. Hooper, and J.R. Burton Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years J Am Coll Cardiol 28 1996 616 626
2. M.P. Savage, J.S. Douglas Jr, D.L. Fischman, C.J. Pepine, S.B. King III, J.A. Werner, S.R. Bailey, P.A. Overlie, S.H. Fenton, J.A. Brinker, M.B. Leon, S. Goldberg Saphenous Vein De Novo Trial Investigators Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts N Engl J Med 337 1997 740 747
3. E.S. Brilakis, C. Lichtenwalter, J.A. de Lemos, M. Roesle, O. Obel, D. Haagen, B. Saeed, C. Gadiparthi, J.K. Bissett, R. Sachdeva, V.V. Voudris, P. Karyofillis, B. Kar, J. Rossen, P. Fasseas, P. Berger, and S. Banerjee A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (Stenting of Saphenous Vein Grafts) trial J Am Coll Cardiol 53 2009 919 928
4. P. Vermeersch, P. Agostoni, S. Verheye, P. Van den Heuvel, C. Convens, N. Bruining, F. Van den Branden, and G. Van Langenhove Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC trial J Am Coll Cardiol 48 2006 2423 2431
5. T. Okabe, J. Lindsay, A.N. Buch, D.H. Steinberg, P. Roy, T.L.P. Slottow, K. Smith, R. Torguson, Z. Xue, L.F. Satler, K.M. Kent, A.D. Pichard, N.J. Weissman, and R. Waksman Drug-eluting stents versus bare metal stents for narrowing in saphenous vein grafts Am J Cardiol 102 2008 530 534
6. A. Assali, Y. Raz, H. Vaknin-Assa, I. Ben-Dor, D. Brosh, I. Teplitsky, S. Fuchs, and R. Kornowski Beneficial 2-years results of drug-eluting stents in saphenous vein graft lesions Eurointervention 4 2008 108 114
7. G. Gioia, A. Benassi, R. Mohendra, K. Chowdhury, I. Masood, and W. Matthai Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts Catheter Cardiovasc Interv 72 2008 13 20
8. R.V. Jeger, S. Schneiter, C. Kaiser, P.O. Bonetti, H. Brunner-La Rocca, M. Handke, S. Osswald, P.T. Buser, and M.E. Pfisterer Drug-eluting stents compared with bare metal stents improve late outcome after saphenous vein graft but not after large native vessel interventions Investigators B. Cardiology 112 2009 49 55
9. T. Pucelikova, R. Mehran, A.J. Kirtane, Y.-H. Kim, M. Fahy, G. Weisz, A.J. Lansky, I. Moussa, W.A. Gray, M.B. Collins, S.K. Kodali, G.W. Stone, J.W. Moses, M.B. Leon, and G. Dangas Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era Am J Cardiol 101 2008 63 68
10. R.K. Ramana, A. Ronan, K. Cohoon, D. Homan, J. Sutherland, L. Steen, J. Liu, H. Loeb, and B.E. Lewis Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease Catheter Cardiovasc Interv 71 2008 886 893
11. P.-H. van Twisk, J. Daemen, N. Kukreja, R.T. van Domburg, and P.W. Serruys Four-year safety and efficacy of the unrestricted use of sirolimus- and paclitaxel-eluting stents in coronary artery bypass grafts Eurointervention 4 2008 311 317
12. P. Vermeersch, P. Agostoni, S. Verheye, P. Van den Heuvel, C. Convens, F. Van den Branden, G. Van Langenhove, and D.R. Investigators Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC trial J Am Coll Cardiol 50 2007 261 267
13. D.O. Williams, R. Holubkov, W. Yeh, M.G. Bourassa, M. Al-Bassam, P.C. Block, P. Coady, H. Cohen, M. Cowley, G. Dorros, D. Faxon, D.R. Holmes, A. Jacobs, S.F. Kelsey, S.B. King III, R. Myler, J. Slater, V. Stanek, H.A. Vlachos, and K.M. Detre Percutaneous coronary intervention in the current era compared with 19851986: the National Heart, Lung, and Blood Institute Registries Circulation 102 2000 2945 2951
14. D. Joyal, K.B. Filion, and M.J. Eisenberg Effectiveness and safety of drug-eluting stents in vein grafts: a meta-analysis Am Heart J 159 2010 159169.e154
15. M.S. Lee, T. Yang, D.E. Kandzari, J.M. Tobis, H. Liao, and E. Mahmud Comparison by meta-analysis of drug-eluting stents and bare metal stents for saphenous vein graft intervention Am J Cardiol 105 2010 1076 1082
16. B.R. Brodie, H. Wilson, T. Stuckey, M. Nussbaum, S. Laurent, B. Bradshaw, A. Humphrey, C. Metzger, J. Hermiller, F. Krainin, S. Juk, B. Cheek, P. Duffy, and C.A. Simonton Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (Strategic Transcatheter Evaluation of New Therapies) group J Am Coll Cardiol Intv 2 2009 1105 1112
17. P.A. Lemos, A. Hoye, D. Goedhart, C.A. Arampatzis, F. Saia, W.J. van der Giessen, E. McFadden, G. Sianos, P.C. Smits, S.H. Hofma, P.J. de Feyter, R.T. van Domburg, and P.W. Serruys Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study Circulation 109 2004 1366 1370
18. S.G. Ellis, S.J. Brener, S. DeLuca, E.M. Tuzcu, R.E. Raymond, P.L. Whitlow, and E.J. Topol Late myocardial ischemic events after saphenous vein graft interventionimportance of initially "nonsignificant" vein graft lesions Am J Cardiol 79 1997 1460 1464
19. J. Rodes-Cabau, O.F. Bertrand, E. Larose, J.-P. Dery, S. Rinfret, R. Bagur, G. Proulx, C.M. Nguyen, M. Cote, M.-C. Landcop, J.-R. Boudreault, J. Rouleau, L. Roy, O. Gleeton, G. Barbeau, B. Noel, J. Courtis, G.R. Dagenais, J.-P. Despres, and R. DeLarochelliere Comparison of plaque sealing with paclitaxel-eluting stents versus medical therapy for the treatment of moderate nonsignificant saphenous vein graft lesions: the Moderate Vein Graft Lesion Stenting With the Taxus Stent and Intravascular Ultrasound (VELETI) pilot trial Circulation 120 2009 1978 1986